Home > Financial Ratios > FREDUN PHARMACEUTICALS

FREDUN PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
FREDUN PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for FREDUN PHARMACEUTICALS
Please provide your vote to see the results

FREDUN PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 31.4190.4644.6521.42-16.64

What is the latest Core EBITDA Growth ratio of FREDUN PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of FREDUN PHARMACEUTICALS is 31.41 based on Mar2024 Standalone results.
Year Core EBITDA Growth
Mar202431.41
Mar202390.46
Mar202244.65
Mar202121.42
Mar2020-16.64

How is Core EBITDA Growth of FREDUN PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2024 31.41
-65.28
Mar2023 90.46
102.60
Mar2022 44.65
108.45
Mar2021 21.42
Positive
Mar2020 -16.64 -

Other Financial Ratios of FREDUN PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of FREDUN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
FREDUN PHARMACEUTICALS ₹341.4 Cr -2.7% 8.8% -12.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹407,827.0 Cr -3.1% -3.9% 12.9% Stock Analytics
DIVIS LABORATORIES ₹157,931.0 Cr -2.9% -0.8% 62.5% Stock Analytics
CIPLA ₹117,322.0 Cr 1.1% 0.3% 1.4% Stock Analytics
DR REDDYS LABORATORIES ₹101,116.0 Cr -1.3% -9.4% -0.8% Stock Analytics
ZYDUS LIFESCIENCES ₹94,752.0 Cr -3.7% -5.9% 19.7% Stock Analytics


FREDUN PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
FREDUN PHARMACEUTICALS

-2.7%

8.8%

-12.1%

SENSEX

-2.9%

-0.1%

6.8%


You may also like the below Video Courses